Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods - Biomet Australia Pty Ltd - 208813

Overview

The Therapeutic Goods Act 1989 was enacted by the Parliament of the Commonwealth of Australia to regulate the supply of therapeutic goods, including medicines, medical devices, and other related products. The legislation was introduced to address the need for a cohesive framework governing the safety, quality, and efficacy of therapeutic goods available to the public, ensuring they meet specific standards before reaching the market. One of the key policy objectives of the Act is to protect public health by controlling the therapeutic goods that are imported, manufactured, supplied, or advertised within Australia. The Act provides the Therapeutic Goods Administration (TGA) with the authority to regulate these goods, including the power to cancel entries from the Australian Register of Therapeutic Goods (ARTG) when necessary. This regulatory action is aimed at maintaining high standards in the therapeutic goods market and preventing the distribution of products that do not meet required safety and efficacy criteria.

Scope and Application

The Therapeutic Goods Act 1989 (the Act) applies to various medical devices and therapeutic goods within the Commonwealth of Australia. Specifically, the Act governs the regulation of therapeutic goods to ensure their safety, quality, and efficacy, and it extends to entities and individuals involved in the manufacturing, importation, supply, and advertising of these goods. In this context, the Act applies to the cancellation of entries for specific kinds of medical devices from the Australian Register of Therapeutic Goods (ARTG). The decision to cancel an entry is made under Section 41GP of the Act, which allows for the removal of a therapeutic good from the ARTG if certain criteria are met, such as the non-compliance with conformity assessment procedures. This particular cancellation concerns a CAD/CAM unit, orthopaedic, sponsored by Biomet Australia Pty Ltd and manufactured by Biomet Orthopaedics Inc from the United States of America. The cancellation was necessitated by the manufacturer's failure to apply the appropriate conformity assessment procedures, rendering the declaration made at the time of application incorrect. The cancellation took effect on 23 September 2013, as mandated under Section 41GN(1)(f) of the Act. The Act's application can be extended or restricted through subordinate instruments, which provide additional regulatory details and specific procedural requirements.

Key Provisions

The main operative sections of the Therapeutic Goods Act 1989 that are relevant to this cancellation notice are sections 41FD(f) and 41GN(1)(f). Section 41FD(f) requires that a manufacturer or sponsor of a medical device must declare that the appropriate conformity assessment procedures have been applied to the device before it can be listed in the Australian Register of Therapeutic Goods (ARTG). Section 41GN(1)(f) provides the authority to cancel an entry from the ARTG if it is found that the declaration made under 41FD(f) was incorrect. In this instance, the entry for the CAD/CAM unit, orthopaedic [41018] has been cancelled because the appropriate conformity assessment procedures had not been applied by the manufacturer, leading to an incorrect declaration being made when the device was first registered. The obligations and requirements imposed by the Act on the parties or entities it governs include ensuring that all medical devices meet the necessary standards and undergo the appropriate conformity assessment procedures before being listed in the ARTG. Manufacturers and sponsors must provide accurate declarations regarding the conformity of their products. This is to ensure that the devices listed in the ARTG are safe and effective for use in Australia. For the specific case of the CAD/CAM unit, orthopaedic [41018], the manufacturer, Biomet Orthopaedics Inc, and the sponsor, Biomet Australia Pty Ltd, were required to ensure that the necessary conformity assessment procedures were correctly applied and accurately declared. Failure to comply with the requirements of the Therapeutic Goods Act 1989 can result in various civil and criminal consequences. For the cancellation of an ARTG entry, as outlined in section 41GN(1)(f), the consequences include the removal of the device from the ARTG, which means it can no longer be legally supplied or advertised in Australia. Additionally, under section 41FL of the Act, a person who makes a false or misleading representation in relation to a therapeutic good can be subject to a civil penalty of up to $220,000 for a corporation and $44,000 for an individual, or imprisonment for up to two years, or both, if the court finds the person guilty of an offence. The penalties serve as a deterrent against non-compliance and help maintain the integrity of the ARTG.